AffordableGLP-1Providers Take the quiz
Tool · endpoints only

The timeline, at trial honesty

Most "timeline" tools draw smooth curves nobody measured. This one shows only published endpoints from the pivotal brand trials, applied to your starting weight — with the caveats that make the number mean something: brand products, supervised trials, maximum tolerated doses, wide individual variation, and months of titration before full dose.

Early months are titration: doses start low and step up every 4 weeks, so trial-average loss is not linear and the first weeks are typically modest.

−46 lbat 72 weeks, if your response matched the SURMOUNT-1 average

Averages hide a spread: substantial numbers of participants lost much more and much less.

Endpoints: SURMOUNT-1 (NEJM 2022), STEP-1 (NEJM 2021) — brand products; compounded versions have no equivalent trial data. This tool is informational only and is not medical advice; decisions about medication, dosing, and diet belong with a licensed clinician who knows your history.